Medical Weight Loss in Manchester, CT — Zepbound (Tirzepatide) with Pulmonary Expertise

Excess weight doesn’t just affect how you look — it affects how you breathe. For patients with sleep apnea, COPD, asthma, or pulmonary hypertension, weight is often a direct driver of disease severity. Reducing weight can dramatically improve lung function, reduce nighttime breathing disruptions, lower blood pressure, and restore energy.

At Advanced Pulmonary Care, medical weight loss isn’t a separate service — it’s an extension of the integrative, whole-person care we already provide. Milos Tomic, APRN is uniquely positioned to manage your weight loss journey because he already understands your respiratory health, your medications, and your overall clinical picture.

What Is Zepbound?

Zepbound is the brand name for tirzepatide, an injectable medication developed by Eli Lilly and approved by the FDA specifically for chronic weight management in adults. It works as a dual GLP-1 and GIP receptor agonist — two hormones that regulate appetite, slow gastric emptying, and signal the brain to feel full after eating less food. Zepbound is not a stimulant or appetite suppressant in the traditional sense. It works by mimicking the body’s natural satiety hormones to help you eat less without feeling deprived.

What Results Can You Expect?

• Up to 21% average body weight reduction over 72 weeks
• Significant improvements in blood pressure, blood sugar, and cholesterol
• Improved sleep apnea severity in patients with OSA
• Sustained results when maintained on therapy

Individual results vary based on starting weight, diet, activity level, and adherence.

Who Is Eligible?

Zepbound is FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition — such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease.

Our program is medically supervised from start to finish. This is not an online prescription service — it is a relationship with a clinician who knows your full health history.

• Initial Consultation and Evaluation — A comprehensive review of your health history, current medications, prior weight loss attempts, and relevant lab work. Milos will assess whether Zepbound is appropriate for you and rule out any contraindications.
• Prescription and Dosing — Zepbound is available as a self-injectable pen (KwikPen). Dosing starts low and is gradually increased over several months based on your response and tolerability. Milos guides you through each step and adjusts your dose as needed.
• Ongoing Monitoring and Follow-Up — Regular follow-up appointments ensure the medication is working effectively, side effects are managed, and your overall health remains on track. Milos monitors your weight, vital signs, and any changes in your respiratory or cardiovascular status.
• Lifestyle Integration — Medication alone produces the best results when combined with meaningful lifestyle adjustments. Milos provides practical guidance on nutrition and activity that fits your real life — not a rigid diet plan.

Medical weight loss with Zepbound at Advanced Pulmonary Care is a self-pay service and is not billed through insurance.

Approximate monthly costs:

• Medication (Zepbound KwikPen or vials): approximately $299–$449 per month depending on dose
• Consultation and monitoring visits: call our office for current rates

Please call 860-645-0145 to discuss current pricing before your first appointment. We are happy to walk you through what to expect.

Common Side Effects

Most side effects occur during dose escalation and typically improve over time:

• Nausea (most common, especially early in treatment)
• Reduced appetite
• Constipation or diarrhea
• Mild abdominal discomfort
• Fatigue (usually temporary)

Eating smaller meals and staying well hydrated significantly reduces GI side effects for most patients.

Who Should Not Use Zepbound

Zepbound is not appropriate for patients who are pregnant or planning to become pregnant, patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), patients with a history of pancreatitis, or patients with severe gastrointestinal disease. A thorough clinical evaluation during your consultation will confirm whether Zepbound is safe and appropriate for you.